Daily testosterone enanthate injections: necessary or just extra work?

What did @maxmadsen94 actually say?

Honestly, this is a tough one to fact-check properly. The video caption presents a clear, specific claim: testosterone enanthate has a half-life of 5-6 days, so daily injections are unnecessary and just add hassle. That's a real argument worth examining. But the actual spoken transcript is incoherent, appearing to be a machine-translation artifact or auto-caption failure that bears no relationship to the topic at all.

So what we're fact-checking is the caption's argument, which reads: "Testosteron-Enantat hat 'ne Halbwertszeit von 5-6 Tagen. Du brauchst keine tägliche Injektion, um stabile Spiegel zu halten." Translated: testosterone enanthate has a half-life of 5-6 days and you don't need daily injections to maintain stable levels. That's the core claim. It's a reasonable pharmacokinetic argument. Let's look at whether it actually holds up.

Does the science back this up?

Partially, yes. But the reality is more nuanced than the caption suggests. Testosterone enanthate does have a half-life in the range of 4.5 to 5 days, not the 5-6 days stated, though this varies by individual. What the caption skips over is that half-life and stable serum levels are related but not identical concepts.

Bhasin et al. (2001, New England Journal of Medicine) showed that weekly or biweekly injections of testosterone enanthate produce significant peaks and troughs in serum testosterone. Rastrelli et al. (2018, Asian Journal of Andrology) noted that more frequent dosing, including twice-weekly and even more frequent protocols, demonstrably reduces peak-to-trough variability. This variability is clinically relevant: high peaks can increase hematocrit and estradiol conversion, while troughs can cause symptom recurrence in some patients.

Daily subcutaneous injections, popularized in some TRT communities, do produce flatter curves. The caption dismisses this benefit entirely. That dismissal oversimplifies the pharmacology.

What did they get wrong (or right)?

The half-life figure is close but slightly off. Most pharmacokinetic literature places testosterone enanthate's half-life at approximately 4.5 days, not 5-6. This is a minor point but worth noting when someone positions themselves as an educator.

More importantly, the claim that "you don't need daily injections to maintain stable levels" is true in a literal sense but misleading in practice. You can maintain average testosterone within range on weekly or biweekly dosing. What you cannot do as effectively is minimize peak-to-trough fluctuation. Testosterone cypionate and enanthate on weekly protocols can swing serum levels by 40-50% between injection and trough, per data reviewed in Handelsman (2017, Endocrine Reviews).

The caption gets credit for correctly identifying that daily injections aren't required for basic TRT function. That part is accurate. But framing daily injections as offering nothing beyond "more effort" ignores legitimate clinical reasons some physicians and patients prefer higher-frequency dosing.

What should you actually know?

Your injection frequency should be a clinical decision, not a social media talking point. Here's what the evidence actually supports:

• Testosterone enanthate has a half-life of roughly 4.5 days, meaning levels decline meaningfully between weekly injections.
• Twice-weekly injections reduce peak-to-trough variability compared to once-weekly dosing, per Nieschlag et al. (2004, European Journal of Endocrinology).
• Patients who report mood instability, energy crashes, or libido fluctuations near their injection day may genuinely benefit from more frequent dosing, including twice-weekly protocols.
• Daily subcutaneous injections are used in some clinical settings specifically to flatten the testosterone curve, particularly for patients sensitive to estradiol spikes from high peaks.
• No single injection protocol is universally optimal. Anyone telling you otherwise is selling simplicity over individualized care.

If you are on a regulated telehealth platform, your prescribing clinician should be the one evaluating your trough levels, symptoms, and hematocrit before recommending a protocol change. Social media arguments about half-lives are a starting point, not a clinical protocol.